Human security, social stigma, and global health: the COVID-19 pandemic in Indonesia

Hastoro Dwinantoaji(1*), Sumarni DW(2)

(1) Department of Community and Mental Health Nursing, Faculty of Nursing Universitas Andalas, Padang
(2) Department of Psychiatric, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author


Coronavirus disease 2019 (COVID-19) is now a global public health threat with many medical, ethical, economic, and socialimpacts. COVID-19 has spread worldwide, to many Asian and Middle Eastern countries, the United Statesof America, and European countries. The current COVID-19 pandemic that has devastated Indonesia, has infected and killed more healthcare workers, in particular doctors and nurses, than any other outbreak in the history of this virus. People have basic needs that must be met for them to feel safe and secure. A history of the outbreak of the COVID-19 is brifley showed, before exploring the impact the virus had in Indonesia. During this exploration, some of the key issues arising from the experiences in Indonesia, in addressing the threat of COVID-19 will be reviewed. Drawing on the COVID-19 as the case study, we consider the ways in which the concept of human security expands understanding of its relationship to health. Further, weshow how major public health issues can evolve into security threats.The final section of the article will be an analysis of the lessons learned from COVID-19 and policy implications in addressing health and human security threats.


human security; social stigma; global health; COVID-19; Indonesia;

Full Text:



  1. Caballero-Anthony M. Revisioning human security in Southeast Asia. Asian Perspective 2004;28(3):155-189.
  2. Barnett J, Matthew RA, O’Brien K. Global environmental change and human security. Globalization and Environmental Challenges 2008:355-361. Springer, Berlin, Heidelberg. [].
  3. Evans PM. Human security and East Asia: In the beginning. Journal of East Asian Studies 2004;4(2):263-284. [].
  4. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of internal medicine 2003;163(9):1009-1021. [].
  5. Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. American Journal of Clinical Pathology 2020;153(4):420–421. [].
  6. Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. International Journal of Epidemiology 2020:1-10. [].
  7. Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. New England Journal of Medicine 2020; 382(13):1199–1207. [].
  8. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine 2020;382(10):970-971. [].
  9. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, Nguyen TT, Cao TM, Pham QD. Importation and human-to-human transmission of a novel coronavirus in Vietnam. New England Journal of Medicine 2020;382(9):872-874. [].
  10. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G. First case of 2019 novel coronavirus in the United States. New England Journal of Medicine 2020;382(10):929-936. [].
  11. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity 2020;109:102433. [].
  12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395(10223):497-506. [].
  13. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513. [].
  14. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China, 2020. China CDC Weekly 2020. Epub February 17, 2020.
  15. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 70. [30 March 2020]. World Health Organization 2020. [].
  16. World Health Organization. WHO recommendations to reduce risk of transmission of emerging pathogens from animals to humans in live animal markets 2020. [].
  17. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 80. [9 April 2020]. World Health Organization 2020. [].
  18. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 – [11 March 2020]. [].
  19. Suherdjoko & Hajramurni A. Authorities assure safety as locals protest burial of people with coronavirus. [2 April 2020]. The Jakarta Post 2020. [].
  20. Khalid MO, Zaheer R. The invisible victims—Impact of the pandemic on patients without COVID-19. COVID-19: Transforming Global Health 2020;70(5):s149-s152. [].
  21. Setiati S, Azwar MK. COVID-19 and Indonesia. Acta Medica Indonesiana 2020;52(1):84-89.


Article Metrics

Abstract views : 13043 | views : 10554

Copyright (c) 2020 Hastoro Dwinantoaji, Sumarni DW

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

View My Stats


Creative Commons License
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) by  Universitas Gadjah Mada is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.